(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-0.15%) $77.99
(0.37%) $2.15
(0.06%) $2 310.10
(0.36%) $26.79
(0.09%) $966.20
(-0.38%) $0.929
(-1.10%) $10.87
(-0.13%) $0.797
(0.52%) $91.61
3 days till quarter result
(bmo 2024-05-08)
Expected move: +/- 6.98%
Live Chart Being Loaded With Signals
Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America...
Stats | |
---|---|
今日成交量 | 6.70M |
平均成交量 | 1.32M |
市值 | 4.46B |
EPS | $0 ( 2024-02-14 ) |
下一个收益日期 | ( $0 ) 2024-05-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 61.40 |
ATR14 | $0.108 (0.25%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-09-28 | Zulueta Alfonso G | Sell | 3 493 | Class A Common Stock |
2023-09-28 | Zulueta Alfonso G | Sell | 4 863 | Class A Common Stock |
2023-09-28 | Wilkes David S. | Sell | 4 973 | Class A Common Stock |
2023-09-28 | Wilkes David S. | Sell | 4 863 | Class A Common Stock |
2023-09-28 | Monaghan Matthew E. | Sell | 19 777 | Class A Common Stock |
INSIDER POWER |
---|
-46.62 |
Last 97 transactions |
Buy: 420 799 | Sell: 674 760 |
音量 相关性
Syneos Health Inc 相关性 - 货币/商品
Syneos Health Inc 财务报表
Annual | 2022 |
营收: | $5.39B |
毛利润: | $1.25B (23.26 %) |
EPS: | $2.57 |
FY | 2022 |
营收: | $5.39B |
毛利润: | $1.25B (23.26 %) |
EPS: | $2.57 |
FY | 2021 |
营收: | $5.21B |
毛利润: | $1.22B (23.37 %) |
EPS: | $2.26 |
FY | 2020 |
营收: | $4.42B |
毛利润: | $1.02B (23.05 %) |
EPS: | $1.850 |
Financial Reports:
No articles found.
Syneos Health Inc
Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics in the Phase I to IV of clinical development. This segment also provides individual services, including product development and regulatory consulting, project management, protocol development, investigational site recruitment, clinical monitoring, technology-enabled patient recruitment and engagement, clinical home health, clinical trial diversity, biometric, and regulatory affair services. The Commercial Solutions segment provides commercialization services, including deployment solutions, communications solutions, such as public relations, advertising, and medical communication services; and consulting services to the pharmaceutical, biotechnology, and healthcare industries. The company was formerly known as INC Research Holdings, Inc. and changed its name to Syneos Health, Inc. in January 2018. Syneos Health, Inc. was incorporated in 2010 and is headquartered in Morrisville, North Carolina.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。